The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BOLD-100-001 (TRIO039): A phase 1b dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid cancers: Interim safety, tolerability, and efficacy.
 
Jennifer L. Spratlin
Honoraria - Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical
Research Funding - Celgene (Inst); Sanofi
Travel, Accommodations, Expenses - Astellas Pharma
 
Grainne O´Kane
Honoraria - AstraZeneca Canada; Eisai; Roche
Consulting or Advisory Role - AstraZeneca Canada; Eisai; Incyte; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Rachel Anne Goodwin
Honoraria - Advanced Accelerator Applications; Advanced Accelerator Applications; Eisai; Ipsen; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Astellas Pharma; AstraZeneca Canada; Eisai; Incyte; Ipsen; Merck; MSD; Pfizer; Roche Canada; Taiho Pharmaceutical
Speakers' Bureau - Advanced Accelerator Applications/Novartis; Eisai; Merck; Mylan; Pfizer
Research Funding - Eisai; Ipsen
 
Elaine McWhirter
Consulting or Advisory Role - BMSi; Merck; Novartis; Pfizer; Sanofi
Research Funding - BMSi; Merck
 
Darby Thompson
No Relationships to Disclose
 
Khalif Halani
No Relationships to Disclose
 
Michelle Jones
Employment - Bold Therapeutics; Qu Biologics
Stock and Other Ownership Interests - Arbutus Biopharma (I); Bold Therapeutics
Consulting or Advisory Role - Bold Therapeutics; Symvivo
 
Malcolm Snow
Employment - Bold Therapeutics
Stock and Other Ownership Interests - Bold Therapeutics
 
Edward Russell McAllister
Employment - Bold Therapeutics; Intezyne Technologies
Leadership - Bold Therapeutics; Intezyne Technologies
Stock and Other Ownership Interests - Bold Therapeutics; Intezyne Technologies
 
Andres Machado
No Relationships to Disclose
 
Yasmin Lemmerick
Research Funding - Bold Therapeutics (Inst)
 
Jim Pankovich
Employment - Bold Therapeutics
Leadership - Bold Therapeutics
Stock and Other Ownership Interests - Bold Therapeutics
Research Funding - Bold Therapeutics